Cadre Holdings, Inc.

CDRE NYSE SEC CIK 1860543
Follow Cadre Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $202.9M +30.2% vs same quarter last year
Net income $16M +46.1% vs same quarter last year
EPS, diluted $0.37 +37% vs same quarter last year
Operating cash flow $22.9M +2% vs same quarter last year
Revenue by quarter
$176M
$130.1M
$157.1M
$155.9M
$167.2M
$155.4M
$207.1M
$202.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
$0$200M$400M$600M$800MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$610.3M$44.1M
FY24$567.6M$36.1M
FY23$482.5M$38.6M
FY22$457.8M$5.8M
FY21$427.3M$12.7M
FY20$404.6M$38.5M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2542.5%11%7.2%
FY2441.1%11.8%6.4%
FY2341.6%11.7%8%
FY2238.4%3.7%1.3%
FY2139.9%12.1%3%
FY2037.8%12.3%9.5%
FY19---
Free cash flowOperating cash flow minus capital expenditure
$0$20M$40M$60M$80MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$56.8M
FY24$26.1M
FY23$66.5M
FY22$41.9M
FY21$37.3M
FY20$40.7M
FY19-
Returned to shareholdersDividends paid and shares bought back
$0$5M$10M$15M$20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividends
FY25$15.4M
FY24$13.9M
FY23$12M
FY22$11.5M
FY21$12.8M
FY20-
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Cadre
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearCadreHealthcare median
FY257.2%−30.6%
FY246.4%−47%
FY238%−58%
FY221.3%−80.4%
FY213%−71.8%
FY209.5%−62.2%
FY19-−46.2%